五个欧洲国家全科医生对阿尔茨海默病早期及痴呆前诊断的态度——一项MOPEAD项目调查
General practitioners' attitude toward early and pre-dementia diagnosis of AD in five European countries-A MOPEAD project survey.
作者信息
Sannemann Lena, Müller Theresa, Waterink Lisa, Zwan Marissa, Wimo Anders, Stomrud Erik, Pinó Susana, Arrufat Jordi, Rodríguez-Gomez Octavio, Benaque Alba, Bon Jaka, Ferreira Daniel, Johansson Gunilla, Dron Amanda, Dumas Annette, Georges Jean, Kramberger Milica G, Visser Pieter Jelle, Winblad Bengt, Campo Laura, Boada Mercè, Jessen Frank
机构信息
Department of Psychiatry University of Cologne Faculty of Medicine and University Hospital Cologne Cologne Germany.
Department of Neurology Alzheimer Center Amsterdam, Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam the Netherlands.
出版信息
Alzheimers Dement (Amst). 2021 Feb 23;13(1):e12130. doi: 10.1002/dad2.12130. eCollection 2021.
INTRODUCTION
General practitioners (GPs) play a key role in early identification of dementia, yet diagnosis is often missed or delayed in primary care. As part of the multinational Models of Patient Engagement for Alzheimer's Disease project, we assess GPs' attitude toward early and pre-dementia diagnosis of AD and explore barriers to early diagnosis.
METHODS
Our survey covered general attitude toward early diagnosis, diagnostic procedures, resources, and opinion on present and future treatment options across five European countries.
RESULTS
In total 343 GPs completed the survey; 74% of GPs indicated that an early diagnosis is valuable. There were country-specific differences in GPs' perceptions of reimbursement and time available for the patient. If a drug were available to slow down the progression of AD, 59% of the GPs would change their implementation of early diagnosis.
DISCUSSION
Our findings provide insight into GPs' attitudes by exploring differences in perception and management of early diagnosis.
引言
全科医生（GPs）在痴呆症的早期识别中起着关键作用，但在初级保健中，诊断往往被遗漏或延迟。作为跨国阿尔茨海默病患者参与模式项目的一部分，我们评估了全科医生对阿尔茨海默病早期和痴呆前期诊断的态度，并探讨了早期诊断的障碍。
方法
我们的调查涵盖了五个欧洲国家对早期诊断、诊断程序、资源以及对当前和未来治疗选择的总体态度。
结果
共有343名全科医生完成了调查；74%的全科医生表示早期诊断很有价值。全科医生对报销和可用于患者的时间的看法存在国别差异。如果有一种药物可以减缓阿尔茨海默病的进展，59%的全科医生会改变他们早期诊断的实施方式。
讨论
我们的研究结果通过探索早期诊断认知和管理方面的差异，深入了解了全科医生的态度。
Zotero 插件